Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Error occurred: cannot get document summary
The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U, Jiang WG, Sharma AK, Mokbel K.
Anticancer Res. 2012 Feb;32(2):671-4.
Related citations
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY, Ho CM, Bau DT, Yang SF, Liu SH, Lin PH, Lin TH, Tien N, Shih MC, Lu JJ.
Anticancer Res. 2012 Feb;32(2):475-82.
Vitamin D and cellular Ca2+ signaling in breast cancer.
Sergeev IN.
Anticancer Res. 2012 Jan;32(1):299-302. Review.
1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
Lopes N, Carvalho J, Durães C, Sousa B, Gomes M, Costa JL, Oliveira C, Paredes J, Schmitt F.
Anticancer Res. 2012 Jan;32(1):249-57.
Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells.
Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M.
Anticancer Res. 2012 Jan;32(1):45-52.
Chemopreventive potential of black cohosh on breast cancer in Sprague-Dawley rats.
Einbond LS, Soffritti M, Degli Esposti D, Tibaldi E, Lauriola M, Bua L, He K, Genovese G, Su T, Huggins L, Wang X, Roller M, Wu HA.
Anticancer Res. 2012 Jan;32(1):21-30.
Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy.
Nawa M, Osada S, Morimitsu K, Nonaka K, Futamura M, Kawaguchi Y, Yoshida K.
Anticancer Res. 2012 Jan;32(1):13-9.
Synchronous double tumor of breast cancer and gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: report of a case.
Takeuchi H, Hiroshige S, Hashimoto K, Kusumoto T, Yoshikawa Y, Muto Y.
Anticancer Res. 2011 Dec;31(12):4481-4.
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.
Mirchandani D, Roses DF, Inghirami G, Zeleniuch-Jacquotte A, Cangiarella J, Guth A, Safyan RA, Formenti SC, Pagano M, Muggia F.
Anticancer Res. 2011 Dec;31(12):4401-5.
Impact of cyclooxygenase-2 in breast cancer.
Hoellen F, Kelling K, Dittmer C, Diedrich K, Friedrich M, Thill M.
Anticancer Res. 2011 Dec;31(12):4359-67. Review.
Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier.
Lee KY, Kim YJ, Yoo H, Lee SH, Park JB, Kim HJ.
Anticancer Res. 2011 Dec;31(12):4307-13.
Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
Cai FF, Kohler C, Zhang B, Chen WJ, Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ, Zhong XY.
Anticancer Res. 2011 Dec;31(12):4267-71.
Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N, Jiang WG, Newbold RF, Mokbel K.
Anticancer Res. 2011 Dec;31(12):4115-25.
Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo.
Singh NP, Lai HC, Park JS, Gerhardt TE, Kim BJ, Wang S, Sasaki T.
Anticancer Res. 2011 Dec;31(12):4111-4.
Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections.
Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR.
Anticancer Res. 2011 Dec;31(12):4053-60.
3D breast ultrasound: a significant predictor in breast cancer reduction under pre-operative chemotherapy.
Warm M, Duda V, Eichler C, Harbeck N, Gossmann A, Thomas A, Hoopmann M, Ohlinger R, Breidenbach M, Kates RE.
Anticancer Res. 2011 Nov;31(11):4039-42.
Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
Kopp HG, Krauss K, Fehm T, Staebler A, Zahm J, Vogel W, Kanz L, Mayer F.
Anticancer Res. 2011 Nov;31(11):4025-30.
Measurement of pessimism: hopelessness scale in healthy study subjects, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland.
Eskelinen M, Ollonen P.
Anticancer Res. 2011 Nov;31(11):4019-23.
Assessment of 'cancer-prone personality' characteristics in healthy study subjects and in patients with breast disease and breast cancer using the commitment questionnaire: a prospective case-control study in Finland.
Anticancer Res. 2011 Nov;31(11):4013-7.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on